… on the safety of biological therapies in psoriasis patients with … positive patients treated with
anti-tumor necrosis factor (TNF) … with HBV using ustekinumab and secukinumab for psoriasis …

… Nevertheless, safety data are scarce for the use of biologics … with psoriasis treated with
biologics in a real-world setting are … /23 inhibitor (IL-12/23i; ustekinumab), and IL-17 inhibitor (IL-…

… in psoriasis, CD, and ulcerative colitis by ustekinumab[17-19], … A retrospective study on 44
patients with resolved HBV who … A prospective multicenter study on 22 patients with CHB with …

… A recent multicenter, retrospective study evaluated the safety of adalimumab in … of TNF-α
inhibitors in treating psoriasis and IBD may be a safe and effective option after receiving organ …

… While larger studies are needed to further explore the safety … suggests it may be an
effective therapeutic option in this … undergoing anti-tumor necrosis factor therapy or DMARDs …

… world setting by means of a retrospective single center study, … In addition to those cases, in
one case with acute hepatitis B [… treated with adalimumab, etanercept or ustekinumab in daily …

… This was a retrospective cohort study of patients with … cause hepatitis B or C reactivation than
anti-tumor necrosis factor-… , a multicentric prospective cohort study involving 63 patients with …

… treatment option for patients with occult or chronic HBV infection … the retrospective multicenter
study in 20 patients with plaque … psoriasis patients with chronic hepatitis B or C [Citation76]. …

… Safety and effectiveness of ustekinumab and antitumour … viral hepatitis B or C: a
retrospective, multicentre study in a clinical setting. Br J Dermatol. 2013;168:609-616. …

… about safety data in patients with hepatitis B virus, hepatitis C virus … Antitumor necrosis
factor-alpha (anti-TNF-α) agents … retrospective study analyzed the effects of ustekinumab in 44 …